Financhill
Sell
49

SBI Quote, Financials, Valuation and Earnings

Last price:
$7.69
Seasonality move :
0.11%
Day range:
$7.68 - $7.72
52-week range:
$7.60 - $8.29
Dividend yield:
3.47%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
63.1K
Avg. volume:
50.4K
1-year change:
-1.03%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Period Ending 2016-11-30 2017-11-30 2018-11-30 2019-11-30 2020-11-30
Revenue $683.1K $8.8M $1.7M $13M $5.3M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $689.2K $678.3K $640.2K $635K $797.4K
Other Inc / (Exp) -$56.7K $161.6K -$218.5K -$90.7K -$1.1M
Operating Expenses $960.7K $1.2M $1.4M $1.5M $1.2M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$277.6K $7.6M $319.2K $11.5M $4.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$277.6K $7.6M $319.2K $11.5M $4.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$277.6K $7.6M $319.2K $11.5M $4.1M
 
Basic EPS (Cont. Ops) -$0.02 $0.54 $0.02 $0.82 $0.29
Diluted EPS (Cont. Ops) -$0.02 $0.54 $0.02 $0.82 $0.29
Weighted Average Basic Share $14.8M $14M $13.1M $14M $14.2M
Weighted Average Diluted Share $14.8M $14M $13.1M $14M $14.2M
 
EBITDA -- -- -- -- --
EBIT -$277.6K $7.6M $319.3K $11.5M $4.1M
 
Revenue (Reported) $683.1K $8.8M $1.7M $13M $5.3M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -$277.6K $7.6M $319.3K $11.5M $4.1M
Period Ending 2020-12-28 2021-12-28 2022-12-28 2023-12-28
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2020-12-28 2021-12-28 2022-12-28 2023-12-28
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2013-12-28 2014-12-28 2015-12-28 2016-12-28 2017-12-28
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2016-11-30 2017-11-30 2018-11-30 2019-11-30 2020-11-30
Cash and Equivalents -- -- -- -- --
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses $29K $29K $76.3K $63.9K $18.6K
Other Current Assets -- -- -- -- --
Total Current Assets $2.9M $2.7M $2.6M $2.5M $2.4M
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments $187.8M $190.1M $183.7M $189.6M $189.9M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $190.6M $192.8M $186.3M $192M $192.2M
 
Accounts Payable $728K $1.4M $1.5M $387.4K $331K
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $865.2K $1.6M $1.6M $478.3K $422.6K
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $47.6M $48.3M $48.3M $47.3M $47.3M
 
Common Stock $2.6M $2.6M $614.1K $614.1K $614.1K
Other Common Equity Adj -- -- -- -- --
Common Equity $140.4M $142M $137.3M $144.2M $144.3M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $143M $144.6M $137.9M $144.8M $144.9M
 
Total Liabilities and Equity $190.6M $192.8M $186.3M $192M $192.2M
Cash and Short Terms -- -- -- -- --
Total Debt -- -- -- -- --
Period Ending 2017-05-31 2018-05-31 2019-05-31 2020-05-31 2021-05-31
Cash and Equivalents -- -- -- -- --
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses $44.9K $37.3K $82.2K $69.8K $56.5K
Other Current Assets -- -- -- -- --
Total Current Assets $3.5M $2.5M $2.5M $2.5M $2.4M
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments $191.5M $187.7M $190.9M $184.2M $196.5M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $195M $190.2M $193.5M $186.6M $198.9M
 
Accounts Payable $644K $1.3M $2.7M $1.3M $1.6M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $1M $1.4M $2.8M $1.4M $1.7M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $47.7M $48.1M $49.6M $48.2M $50.2M
 
Common Stock $2.6M $2.6M $614.1K $614.1K $614.1K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $147.3M $142.2M $143.9M $138.5M $148.7M
 
Total Liabilities and Equity $195M $190.2M $193.5M $186.6M $198.9M
Cash and Short Terms -- -- -- -- --
Total Debt -- -- -- -- --
Period Ending 2016-11-30 2017-11-30 2018-11-30 2019-11-30 2020-11-30
Net Income to Stockholders -$277.6K $7.6M $319.2K $11.5M $4.1M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$82.9K $140.7K $179K $110.9K $51.8K
Change in Inventories -- -- -- -- --
Cash From Operations $7.1M $5.6M $7M $4.7M $4M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -$6.7M -$5.6M -$5.3M -$4.7M -$4M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -$1.7M -- --
Other Financing Activities -$409.3K $27.6K $7K -$7K --
Cash From Financing -$7.1M -$5.6M -$7M -$4.7M -$4M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2020-12-28 2021-12-28 2022-12-28 2023-12-28
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2020-12-28 2021-12-28 2022-12-28 2023-12-28
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2013-12-28 2014-12-28 2015-12-28 2016-12-28 2017-12-28
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Uber Stock a Buy on the Dip?
Is Uber Stock a Buy on the Dip?

Shares of Uber Technologies (NYSE:UBER) have been fading fast in…

Is AMD Stock an All-Time Buy?
Is AMD Stock an All-Time Buy?

Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 43x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
57
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
64
ARQQ alert for Dec 27

Arqit Quantum [ARQQ] is down 3.22% over the past day.

Buy
64
QMCO alert for Dec 27

Quantum [QMCO] is up 4.72% over the past day.

Buy
65
ALGS alert for Dec 27

Aligos Therapeutics [ALGS] is down 4.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock